Kerry Stokes’ Media Executives and Orthocell
Seven West Media shows a strong interest in ASX-listed medtech company Orthocell. This Perth-based firm specializes in cell regeneration therapies and was founded in 2007 as a spin-off from the University of Western Australia.
Orthocell Overview
- ASX-listed medtech company
- Located in Perth
- Specializes in cell regeneration therapies
- Founded in 2007 from the University of Western Australia
- Market capitalization around $300 million
- Stock value increased approximately 80% over the past year
“It’s a Perth-based, ASX-listed medtech that makes cell regeneration therapies.”
Although Orthocell’s performance is notable, it remains one among many small medtech companies listed on the ASX.
Subscription Offer
Subscribers can gift 5 articles to anyone each month, offering access to focused insights on relevant topics, people, and companies.
Summary
The strong market performance of Orthocell and media executives’ interest highlight the growing attention to promising medtech companies on the ASX.
Author's summary: Orthocell, a growing Perth medtech firm with notable gains, gains media spotlight amidst many ASX-listed small medtech companies.